News

OpenAI Accused of Privacy Breaches in Massive Lawsuit

Lawsuit Alleges OpenAI's Unethical Data Practices: Are Our Privacy Rights at Risk

TL;DR

OpenAI, the creator of ChatGPT, faces a class-action lawsuit alleging it has collected vast amounts of personal data without consent.
The lawsuit accuses OpenAI and Microsoft of potentially causing "civilizational collapse" and violating multiple privacy laws.

Introduction

In a class-action lawsuit, an anonymous group accuses OpenAI, the organization behind ChatGPT, of stealing huge amounts of personal data for training its AI models. Microsoft Corporation, a reported investor in OpenAI, is also named in the lawsuit.

Key Facts

OpenAI is alleged to have violated privacy laws by secretly scraping 300 billion words from the internet, including personal data obtained

EU's AI Legislation: Boosting Security or Stifling Innovation?

Proposed EU AI legislation faces strong opposition from top executives, who argue it could jeopardize Europe's tech competitiveness and innovation.

TLDR:

The proposed EU AI legislation is under fire from over 160 executives who believe it jeopardizes Europe's tech competitiveness.
The disagreement centers around the shift from a risk-based to a technology-based approach to regulation.

Introduction:

The proposed Artificial Intelligence legislation by the EU has sparked a contentious debate. Critics, including more than 160 top executives from various industries, suggest that the new laws could undermine Europe's technological prowess and sovereignty. Their primary concerns revolve around stifled innovation and high compliance costs.

Key Facts:

This month, EU lawmakers agreed on draft rules requiring AI systems like ChatGPT to disclose AI-generated

AI-Built Drug Goes To Clinical Trials

Could the future of medicine be written by artificial intelligence? The first entirely AI-generated drug enters human trials, opening a new chapter in healthcare.

TLDR:

First-ever completely AI-designed drug, created by biotech startup Insilico Medicine, commences human clinical trials.
The drug is a potential treatment for idiopathic pulmonary fibrosis (IPF), a lethal, chronic lung disease.

Introduction

Insilico Medicine, a biotech startup from Hong Kong, has innovated in healthcare by generating the first-ever drug entirely designed by artificial intelligence. The drug, INS018_055, is now entering Phase II of human clinical trials. The drug aims to treat idiopathic pulmonary fibrosis, a dangerous lung disease that currently affects roughly 100,000 people in the U.S.

Key Facts:

Insilico Medicine has over $400 million in funding

Runway AI Secures $141M in Funding

Revolutionizing Content Creation: How One Startup Runway ML's $141 Million Funding Round is Shaping the Future of Generative AI in Multimedia

TL;DR

Generative AI startup Runway secures $141 million extension to its Series C round of funding from notable firms including Google, Nvidia, and Salesforce.
Runway, focusing on generative AI for multimedia content creators, plans to use the funding to enhance research efforts and expand the team.

Introduction

Today marks a significant milestone in the world of generative AI funding. Runway, a company that develops generative AI tools for multimedia creators, announced a $141 million extension to its Series C funding round, following close on the heels of Inflection AI's substantial investment.

Key Facts

Runway was founded in 2018 by

Cathie Wood's Bold Bets on AI Stocks

Investing in the Future: The Power of Artificial Intelligence with Cathie Wood and Five Game-Changing Companies

TL;DR:

Cathie Wood from Ark Invest predicts massive growth for software companies thriving on AI, which she believes will generate $8 for every $1 of hardware sold by companies like Nvidia.
Wood has named UiPath, Twilio, Teladoc, and Tesla as key AI-driven stocks to watch out for, with Tesla being the "biggest artificial intelligence play".

Introduction:

Investor Cathie Wood of Ark Invest has made waves in the finance world with her predictions on AI's disruptive potential. Not only has she bet big on AI, but she's also highlighted software providers that will profit from hardware giants like Nvidia. Among

Senator Calls To Label AI Content

US Senator calls for tech giants to label and monitor AI-generated content, highlighting the urgent need to address misinformation risks in the digital space.

TL;DR

U.S Senator Michael Bennet urges tech companies to label AI-generated content and monitor misinformation.
Bennet emphasizes the potential risks of AI content for public discourse and electoral integrity.

Introduction

In a recent initiative, U.S Senator Michael Bennet has called on tech giants involved with artificial intelligence (AI) to label AI-generated content. His concern lies in the potential misinformation caused by such content, which could undermine trust and economic stability, particularly in the context of politics.

Key Facts

Bennet sent a letter to major tech firms, including OpenAI, Microsoft, Meta, Twitter, and Alphabet, on June 29.
The

OpenAI Accused of Privacy Breaches in Massive Lawsuit

TL;DR

Introduction

Key Facts

EU's AI Legislation: Boosting Security or Stifling Innovation?

TLDR:

Introduction:

Key Facts:

AI-Built Drug Goes To Clinical Trials

TLDR:

Introduction

Key Facts:

Runway AI Secures $141M in Funding

TL;DR

Introduction

Key Facts

Cathie Wood's Bold Bets on AI Stocks

TL;DR:

Introduction:

Senator Calls To Label AI Content

TL;DR

Introduction

Key Facts

Featured

Reasoners - A New Approach to Smarter AI

Generative AI - The New Compiler

How Prompt Keywords (Magic Words) Optimize Language Model Performance

Popular Tags

News

Prompt Engineering

LLM

ChatGPT

Lesson

News

Posts tagged with News

TL;DR

Introduction

Key Facts

TLDR:

Introduction:

Key Facts:

TLDR:

Introduction

Key Facts:

TL;DR

Introduction

Key Facts

TL;DR:

Introduction:

TL;DR

Introduction

Key Facts

Prompt Engineering Institute

Featured

Popular Tags

News

Prompt Engineering

LLM

ChatGPT

Lesson